Komal Jhaveri, MD, FACP, part head, Endocrine Remedy Analysis Program, medical director, Early Drug Growth Service, Patricia and James Cayne Chair for Junior...
Sino Biopharmaceutical (HK:1177) has launched an replace.
Sino Biopharmaceutical Restricted has introduced the profitable completion of part III scientific trials for its revolutionary drug...
